Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Exclusion Criteria

• •History of behavioral or cognitive impairment or psychiatric condition
• •Hypersensitivity, including allergy, to any component of vaccines, medicinal products or medical equipment whose use is foreseen in this study
• •Abnormal function of the immune system
• •Receipt of any influenza vaccine within 6 months prior to enrollment in this study, or plan to receive influenza vaccine prior to the Day 22 blood collection
• •Any other clinical condition that, in the opinion of the Investigator, might interfere with the results of the study or pose additional risk to the subject due to participation in the study
• •Additional eligibility criteria may be discussed by contacting the site.